Current:Home > InvestMany cancer drugs remain unproven years after FDA's accelerated approval, study finds -Streamline Finance
Many cancer drugs remain unproven years after FDA's accelerated approval, study finds
View
Date:2025-04-14 18:03:19
The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
"Five years after the initial accelerated approval, you should have a definitive answer," said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. "Thousands of people are getting those drugs. That seems a mistake if we don't know whether they work or not."
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Patients get access to drugs earlier, but the tradeoff means some of the medications don't pan out. It's up to the FDA or the drugmaker to withdraw disappointing drugs, and sometimes the FDA has decided that less definitive evidence is good enough for a full approval.
The new study found that between 2013 and 2017, there were 46 cancer drugs granted accelerated approval. Of those, 63% were converted to regular approval even though only 43% demonstrated a clinical benefit in confirmatory trials.
The research was published in the Journal of the American Medical Association and discussed at the American Association for Cancer Research annual meeting in San Diego on Sunday.
It's unclear how much cancer patients understand about drugs with accelerated approval, said study co-author Dr. Edward Cliff of Harvard Medical School.
"We raise the question: Is that uncertainty being conveyed to patients?" Cliff said.Drugs that got accelerated approval may be the only option for patients with rare or advanced cancers, said Dr. Jennifer Litton of MD Anderson Cancer Center in Houston, who was not involved in the study.
It's important for doctors to carefully explain the evidence, Litton said.
"It might be shrinking of tumor. It might be how long the tumor stays stable," Litton said. "You can provide the data you have, but you shouldn't overpromise."
Congress recently updated the program, giving the FDA more authority and streamlining the process for withdrawing drugs when companies don't meet their commitments.
The changes allow the agency "to withdraw approval for a drug approved under accelerated approval, when appropriate, more quickly," FDA spokesperson Cherie Duvall-Jones wrote in an email. The FDA can now require that a confirmatory trial be underway when it grants preliminary approval, which speeds up the process of verifying whether a drug works, she said.
- In:
- Cancer
- FDA
veryGood! (65385)
Related
- Man charged with murder in death of beloved Detroit-area neurosurgeon
- Arkansas man used losing $20 scratch-off ticket to win $500,000 in play-it-again game
- Eagles release 51-year-old former player nearly 30 years after his final game
- Swiftie who received Taylor Swift's hat at Cincinnati Eras Tour show dies at 16
- Jamaica's Kishane Thompson more motivated after thrilling 100m finish against Noah Lyles
- Angel Reese absent from LSU women's basketball game Friday. What coach Kim Mulkey said
- Connecticut judge sets new primary date for mayor’s race tainted by alleged ballot box stuffing
- White House rejects congressional requests tied to GOP-led House impeachment inquiry against Biden, as special counsel charges appear unlikely
- Louisiana high court temporarily removes Judge Eboni Johnson Rose from Baton Rouge bench amid probe
- Century-overdue library book is finally returned in Minnesota
Ranking
- Kylie Jenner Shows Off Sweet Notes From Nieces Dream Kardashian & Chicago West
- NCAA president says he feels bad for James Madison football players, but rules are rules
- No turkey needed: How to make a vegetarian Thanksgiving spread, including the main dish
- Cricket-mad India readies for World Cup final against Australia in 132,000-seat venue
- Bodycam footage shows high
- Honda recalls nearly 250,000 vehicles including Odyssey, Pilot, Acura models. See a list.
- 'There's people that need water.' Taylor Swift pauses Eras show in Rio to help fans
- Florida State QB Jordan Travis out with leg injury, No. 4 Seminoles rout North Alabama 58-13
Recommendation
North Carolina justices rule for restaurants in COVID
Dogs are coming down with an unusual respiratory illness in several US states
$1.35 billion Mega Millions winner sues mother of his child for disclosing jackpot win
Bangladesh’s top court upholds decision barring largest Islamist party from elections
Meta donates $1 million to Trump’s inauguration fund
A French senator is accused of drugging another lawmaker to rape or sexually assault her
Is China Emitting a Climate Super Pollutant in Violation of an International Environmental Agreement?
Oregon’s first-in-the-nation drug decriminalization law faces growing pushback amid fentanyl crisis